RecruitingNCT06093152

Video Assisted Study of Salbutamol Response in Viral Wheezing

Sponsor

University of Oulu

Enrollment

50 participants

Start Date

Oct 23, 2023

Study Type

OBSERVATIONAL

Conditions

Wheezing

Summary

The study is video assisted cross-over study evaluating the effect of inhaled salbutamol in wheeze in children 6-24 months old.

Eligibility

Min Age: 6 MonthsMax Age: 24 Months

Inclusion Criteria2

Wheezing
Salbutamol-treatment in emergency department prescribed

Exclusion Criteria4

Need for immediate resuscitation
Immediate transfer to ICU
Suspicion of pneumonia based on the auscultation finding
Suspicion of airway foreign body

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSalbutamol

Inhaled salbutamol (SABA, selective beta2-adrenergic receptor agonist) 0,1 mg 4-6 puffs 3-4 times every 20 minutes administered by OptiChamber holding chamber.

Locations(1)

Department of Pediatrics, Oulu University Hospital

Oulu, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06093152

Related Trials

Swiss Paediatric Airway Cohort

NCT0350521612 locations

Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)

NCT0619131574 locations